chr20-45890585-C-CT
Position:
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP6_ModerateBS2
The NM_080749.4(NEURL2):c.406_407insA(p.Ser136LysfsTer15) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00637 in 1,612,316 control chromosomes in the GnomAD database, including 41 homozygotes. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Genomes: 𝑓 0.0047 ( 1 hom., cov: 33)
Exomes 𝑓: 0.0065 ( 40 hom. )
Consequence
NEURL2
NM_080749.4 frameshift
NM_080749.4 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.00
Genes affected
NEURL2 (HGNC:16156): (neuralized E3 ubiquitin protein ligase 2) This gene encodes a protein that is involved in the regulation of myofibril organization. This protein is likely the adaptor component of the E3 ubiquitin ligase complex in striated muscle, and it regulates the ubiquitin-mediated degradation of beta-catenin during myogenesis. Alternative splicing of this gene results in multiple transcript variants. [provided by RefSeq, Jun 2013]
CTSA (HGNC:9251): (cathepsin A) This gene encodes a member of the peptidase S10 family of serine carboxypeptidases. Alternative splicing results in multiple transcript variants, at least one of which encodes a preproprotein that is proteolytically processed to generate two chains that comprise the heterodimeric active enzyme. This enzyme possesses deamidase, esterase and carboxypeptidase activities and acts as a scaffold in the lysosomal multienzyme complex. Mutations in this gene are associated with galactosialidosis. [provided by RefSeq, Nov 2015]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -6 ACMG points.
BP6
Variant 20-45890585-C-CT is Benign according to our data. Variant chr20-45890585-C-CT is described in ClinVar as [Likely_benign]. Clinvar id is 1206356.Status of the report is criteria_provided_single_submitter, 1 stars.
BS2
High Homozygotes in GnomAdExome4 at 40 AR gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
NEURL2 | NM_080749.4 | c.406_407insA | p.Ser136LysfsTer15 | frameshift_variant | 1/2 | ENST00000372518.5 | |
NEURL2 | NM_001278535.2 | c.406_407insA | p.Ser136LysfsTer15 | frameshift_variant | 1/2 | ||
SPATA25 | XM_024451826.2 | c.-2158_-2157insA | 5_prime_UTR_variant | 1/3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
NEURL2 | ENST00000372518.5 | c.406_407insA | p.Ser136LysfsTer15 | frameshift_variant | 1/2 | 1 | NM_080749.4 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00466 AC: 709AN: 152228Hom.: 1 Cov.: 33
GnomAD3 genomes
AF:
AC:
709
AN:
152228
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.00417 AC: 1020AN: 244612Hom.: 5 AF XY: 0.00432 AC XY: 577AN XY: 133568
GnomAD3 exomes
AF:
AC:
1020
AN:
244612
Hom.:
AF XY:
AC XY:
577
AN XY:
133568
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.00655 AC: 9556AN: 1459970Hom.: 40 Cov.: 38 AF XY: 0.00640 AC XY: 4647AN XY: 726182
GnomAD4 exome
AF:
AC:
9556
AN:
1459970
Hom.:
Cov.:
38
AF XY:
AC XY:
4647
AN XY:
726182
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.00466 AC: 710AN: 152346Hom.: 1 Cov.: 33 AF XY: 0.00421 AC XY: 314AN XY: 74506
GnomAD4 genome
AF:
AC:
710
AN:
152346
Hom.:
Cov.:
33
AF XY:
AC XY:
314
AN XY:
74506
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Likely benign
Submissions summary: Benign:3
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not provided Benign:3
Likely benign, no assertion criteria provided | clinical testing | Genome Diagnostics Laboratory, University Medical Center Utrecht | - | - - |
Likely benign, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Oct 01, 2023 | NEURL2: BS2 - |
Likely benign, no assertion criteria provided | clinical testing | Laboratory of Diagnostic Genome Analysis, Leiden University Medical Center (LUMC) | - | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at